Loading viewer...
investor_presentation
Format: PDF investor_presentation
Mettler -Toledo International Inc.Earnings Call Webcast May 10, 2024 Q1 2024 Financial Results
Mettler -Toledo International Inc.Earnings Call Webcast
Q1 2024 Financial Results
Safe Harbor Statement 2
Statements in this presentation which are not historical facts constitute “forward looking statements” within the meaning of
Section 27A of the U.S. Securities Act of 1933 and Section 21E of the U.S. Securities Exchange Act of 1934. These statements involve known and unknown risks, uncertainties and other factors that may cause our or our businesses, actual
results, levels of activity, performance or achievements to be materially different from those expressed or implied by any
forward- looking statements. For a discussion of these risks and uncertainties, please see "Factors Affecting Our Future
Operating Results" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10- K for the most recently completed fiscal year and other reports filed with the SEC from time to
time.Summary Comments
First Quarter 2024 Highlights
Our first quarter results were much better than expected,
although we continued to face reduced market demand,
especially in China, versus the prior year. We also substantially
recovered our previously disclosed delayed product shipments from the fourth quarter of 2023, slightly better than forecast.
Strong execution of our productivity and cost savings initiatives offset significant foreign exchange headwinds and resulted in modest Adjusted EPS growth in the quarter.
We expect soft market conditions in the second quarter of 2024, particularly in China. We remain focused on the diligent
execution of our growth strategies, while continuing to drive
innovation and further strengthen our Company for the future. 3
Above: Our new EVA titrators are ideal for efficiently determining the water
content of challenging samples, and our new control algorithm speeds up reaction rates for faster analyses and cycle times. An automated solvent exchange system ensures safety by minimizing exposure to chemicals. EVA titrators have full compatibility with LabX to enable error -free data
transfer for secure, compliant, and audit -ready workflows.Sales by Geography
Q1 local currency sales growth
(8%) LC$929 $9267% LC 0% LC41% 30% 29%
1Q23 1Q24 1Q23 1Q24 1Q23 1Q24 1Q23 1Q24Americas Europe Total Asia/ROW4
USD in 000's, figures may not foot due to rounding. Local currency (LC) sales growth excludes the impact from changes in foreign exchange rates. Excluding the
benefit from recovering delayed Q4 shipments, LC sales declined about (6%) in Q1 2024 with the Americas (1%), Europe (5%), and A sia/ROW (12%). $520 $525
36% LC (9%) LC$929 $9267% LC 0% LC57% 38% 5%
1Q23 1Q24 1Q23 1Q24 1Q23 1Q24 1Q23 1Q24Laboratory Industrial Total Food RetailSales by Product
Q1 local currency sales growth6
USD in 000's, figures may not foot due to rounding. Local currency (LC) sales growth excludes the impact from changes in foreign exchange rates. Excluding the
Preview truncated — download the full document for the complete content.
investor_presentation
10 Pages
Enbridge Inc. Strategy Power New Energy 2021-2022
investor_presentation
12 Pages
Enbridge
Truist Financial Investor Presentation — March 2019
investor_presentationinvestor_presentation
33 Pages
Truist Financial Corporation
Teva Pharmaceutical Industries Investor Presentation — March 2021
investor_presentationinvestor_presentation
18 Pages
Teva Pharmaceutical Industries